๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Olanzapine treatment of clozapine-induced NMS

โœ Scribed by B. Nemets; V. Geller; N. Grisaru; R. H. Belmaker

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
48 KB
Volume
15
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

โœฆ Synopsis

No Abstract

๐Ÿ“œ SIMILAR VOLUMES

Olanzapine treatment after clozapine ind
Olanzapine treatment after clozapine induced agranulocytosis
โœ P. Lokshin; P. Dorfman; D. Shoshani; P. Wimmer; M. Dossenbach; R. H. Belmaker ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB

Clozapine is an atypical antipsychotic with a signiยฎcant incidence of agranulocytosis. Olanzapine resembles clozapine structurally; however, it lacks a halogen, which has been implicated in agranulocytosis. Both agents have a similar pharmacological proยฎle. We therefore studied olanzapine in patient

Olanzapine treatment for dopaminergic-in
Olanzapine treatment for dopaminergic-induced hallucinations
โœ William G. Ondo; Joel K. Levy; Kevin Dat Vuong; Christine Hunter; Joseph Jankovi ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB

## Abstract Atypical antipsychotic medications with lower affinities for D2 receptors are considered useful alternatives to treat drugโ€induced hallucinations in Parkinson's disease (PD). We conducted a doubleโ€blind, placeboโ€controlled, unforced titration, parallel design study (2:1 drug to placebo